ACP Journal Club. Review: Dabigatran increases MI and reduces mortality compared with warfarin, enoxaparin, or placebo.

作者信息

Cairns John

机构信息

University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Ann Intern Med. 2012 Jun 19;156(12):JC6-11. doi: 10.7326/0003-4819-156-12-201206190-02011.

DOI:10.7326/0003-4819-156-12-201206190-02011

PMID:22711112

Abstract

摘要

相似文献

ACP Journal Club. Review: Dabigatran increases MI and reduces mortality compared with warfarin, enoxaparin, or placebo.

Ann Intern Med. 2012 Jun 19;156(12):JC6-11. doi: 10.7326/0003-4819-156-12-201206190-02011.

ACP Journal Club. Enoxaparin plus idrabiotaparinux was noninferior to enoxaparin plus warfarin for recurrent VTE in acute PE.

Ann Intern Med. 2012 May 15;156(10):JC5-4. doi: 10.7326/0003-4819-156-10-201205150-02004.

ACP Journal Club. Review: Intensive blood pressure control reduces stroke, but not mortality or MI, in type 2 diabetes.

Ann Intern Med. 2013 Jan 15;158(2):JC5. doi: 10.7326/0003-4819-158-2-201301150-02005.

ACP Journal Club. Compared with warfarin, high-dose dabigatran might be cost-effective for preventing stroke in older patients with nonvalvular AF.

Ann Intern Med. 2011 Jun 21;154(12):JC6-12. doi: 10.7326/0003-4819-154-12-201106210-02012.

ACP Journal Club. Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation.

Ann Intern Med. 2011 Sep 20;155(6):JC3-3. doi: 10.7326/0003-4819-155-6-201109200-02003.

ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes.

Ann Intern Med. 2009 Apr 21;150(8):JC4-8. doi: 10.7326/0003-4819-150-8-200904210-02008.

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.

Circulation. 2012 Feb 7;125(5):669-76. doi: 10.1161/CIRCULATIONAHA.111.055970. Epub 2012 Jan 3.

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.

Arch Intern Med. 2012 Mar 12;172(5):397-402. doi: 10.1001/archinternmed.2011.1666. Epub 2012 Jan 9.

ACP Journal Club. Review: enoxaparin during PCI is better than unfractionated heparin for reducing mortality in coronary heart disease.

Ann Intern Med. 2012 May 15;156(10):JC5-2. doi: 10.7326/0003-4819-156-10-201205150-02002.

ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment.

Ann Intern Med. 2011 May 17;154(10):JC5-06, JC5-07. doi: 10.7326/0003-4819-154-10-201105170-02006.

引用本文的文献

Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation.

Clin Pharmacol Ther. 2013 Aug;94(2):269-76. doi: 10.1038/clpt.2013.83. Epub 2013 Apr 25.

New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures.

Intern Emerg Med. 2013 Mar;8(2):115-22. doi: 10.1007/s11739-012-0886-6. Epub 2012 Dec 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验